The merged data suggested that the RBP-4 levels did not change significantly in patients with psoriasis vulgaris after treatment (SMD = -0.33, 95%CI: −0.84, 0.19, p > 0.05; Figure 3). The gene discussed is RBP4; the disease is psoriasis vulgaris.